The aim of this review is to collect and discuss data regarding the chemical and biological aspects of radiolabelled VEGF derivatives and VEGFRs’ ligands used in nuclear medicine for cancer diagnosis and combination targeted radionuclide tumour therapy. The gene discussed is VEGFA; the disease is cancer.